Korea Bio-Gen Co.Ltd (318000) — Capital Reinvestment Ratio
Latest as of March 2026:
0.29x
Korea Bio-Gen Co.Ltd (318000) has a Capital Reinvestment Ratio of 0.29x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩145.77 Million) in capital expenditures (₩42.14 Million). See free cash flow generation of Korea Bio-Gen Co.Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.29x
Capex / Operating Cash Flow
Operating Cash Flow
₩145.77 Million
KRW
Capital Expenditures
₩42.14 Million
KRW
Data as of
Mar 2026
Most recent filing
Korea Bio-Gen Co.Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks Korea Bio-Gen Co.Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for Korea Bio-Gen Co.Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for Korea Bio-Gen Co.Ltd from 2017 to 2025. For live market cap and broader valuation context, see Korea Bio-Gen Co.Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.06x | ₩7.34 Billion | ₩462.42 Million | ▼ -94.7% |
| 2024 | 1.19x | ₩4.29 Billion | ₩5.12 Billion | ▲ +366.1% |
| 2023 | 0.26x | ₩9.47 Billion | ₩2.42 Billion | ▼ -81.3% |
| 2022 | 1.37x | ₩1.67 Billion | ₩2.29 Billion | ▲ +79.6% |
| 2021 | 0.76x | ₩3.09 Billion | ₩2.36 Billion | ▲ +125.5% |
| 2020 | 0.34x | ₩2.58 Billion | ₩872.46 Million | ▼ -59.4% |
| 2019 | 0.83x | ₩3.05 Billion | ₩2.55 Billion | ▲ +96.7% |
| 2018 | 0.42x | ₩1.98 Billion | ₩840.93 Million | ▼ -24.6% |
| 2017 | 0.56x | ₩1.38 Billion | ₩777.66 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow